Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

480
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
480
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

327
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
327
Positive Symptoms of Schizophrenia: Hallucinations and Delusions01:30

Positive Symptoms of Schizophrenia: Hallucinations and Delusions

195
Schizophrenia is a complex mental health disorder that can manifest with various positive symptoms, including thought, movement, and behavior disorders. These symptoms significantly disrupt cognitive and motor functions, leading to profound effects on an individual's ability to engage with the world.
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes...
195
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

639
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
639
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

521
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
521
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

596
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
596

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep brain stimulation of the globus pallidus internus in FBXO7-related parkinsonism-dystonia.

Parkinsonism & related disorders·2026
Same author

"Cingulate Island" Sign in a Patient with Reversible Parkinsonism due to a Portosystemic Shunt.

Annals of Indian Academy of Neurology·2026
Same author

Ictal FDG-PET Outscores Ictal SPECT in Pediatric Epilepsia Partialis Continua: An Illustrative Example.

Clinical nuclear medicine·2026
Same author

Clinical relevance of automated cerebrospinal fluid amyloid and tau biomarkers in Indian patients with early onset cognitive decline: Insights from the AIIMS-Delhi Study Cohort of Early/late oNset Dementia (ASCEND).

Journal of Alzheimer's disease : JAD·2026
Same author

Comparative Evaluation of [68Ga]Ga-DOTA.SA.FAPi and [18F]FDG PET/CT in Metastatic Breast and Lung Cancer: Semiquantitative, Volumetric and Prognostic Assessment.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Ring-enhancing lesions in an immunocompetent patient.

Practical neurology·2026

Related Experiment Video

Updated: Aug 9, 2025

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
06:45

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

2.9K

Drug-Induced Movement Disorders.

Sanjay Pandey1, Yuvadee Pitakpatapee2, Weerawat Saengphatrachai2

  • 1Department of Neurology, Amrita Hospital, Faridabad, Delhi National Capital Region, India.

Seminars in Neurology
|February 24, 2023
PubMed
Summary
This summary is machine-generated.

Drug-induced movement disorders (DIMDs) can stem from various medications beyond antipsychotics. Diagnosing DIMDs hinges on linking drug use to abnormal movements, with basal ganglia dysfunction implicated.

More Related Videos

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
05:52

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis

Published on: November 21, 2013

15.0K
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

3.9K

Related Experiment Videos

Last Updated: Aug 9, 2025

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
06:45

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

2.9K
Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
05:52

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis

Published on: November 21, 2013

15.0K
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

3.9K

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Drug-induced movement disorders (DIMDs) are frequently linked to antipsychotic medications but can also arise from antidepressants, antihistamines, antiepileptics, antiarrhythmics, and gastrointestinal drugs.
  • Abnormal involuntary movements are key indicators, necessitating a clear causal relationship between drug exposure and symptom onset for diagnosis.

Approach:

  • This review examines the phenomenology, diagnostic criteria, pathophysiology, and management strategies for DIMDs.
  • It highlights the diagnostic challenge of establishing drug causality and the complex treatment scenarios, particularly when discontinuing causative agents like antipsychotics is difficult.

Key Points:

  • Establishing a causal link between medications and movement disorders is crucial for diagnosing DIMDs.
  • The basal ganglia are a primary site implicated in the pathophysiology of many DIMDs.
  • Treatment can be challenging, especially when the offending drug is essential for managing underlying conditions.

Conclusions:

  • Further research is essential to elucidate the mechanisms of DIMDs and develop medications with improved safety profiles.
  • Understanding DIMDs is critical for managing patients experiencing adverse drug reactions affecting motor function.